• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

年龄对老年女性导管原位癌的结局和治疗的影响。

The effect of age in the outcome and treatment of older women with ductal carcinoma in situ.

机构信息

Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY, USA.

出版信息

Breast. 2011 Feb;20(1):71-7. doi: 10.1016/j.breast.2010.07.005. Epub 2010 Aug 23.

DOI:10.1016/j.breast.2010.07.005
PMID:20739181
Abstract

The effect of increasing age on outcomes and type of treatment given to older women with ductal carcinoma in situ (DCIS) was assessed. 646 women ≥60 years old (654 cases) receiving surgery for DCIS at Memorial Sloan-Kettering Cancer Center between 2000 and 2007 (8 bilateral) had wide local excision (WLE; 37%), WLE plus radiotherapy (WLE+RT; 41%), or mastectomy (22%). 45%, 38%, and 16% of patients 60-69 years, 70-79 years, and ≥80 years, respectively, received WLE+RT (P<0.001) and 25%, 20%, and 13%, received mastectomy, respectively (P<0.001). Age (P<0.001), grade (P<0.001), and necrosis (P<0.01) were highly associated with treatment. Four-year local recurrence was 3.6%. Overall local recurrence differed by treatment (mastectomy, 0%; WLE, 5%; WLE+RT, 4%; P<0.00001) but not age. It is possible to identify older women with DCIS in whom the risk of recurrence is acceptably low after WLE alone. WLE alone may be a viable treatment option for select older women with DCIS.

摘要

评估了年龄增长对老年女性导管原位癌(DCIS)患者的结局和治疗类型的影响。2000 年至 2007 年间,纪念斯隆-凯特琳癌症中心(Memorial Sloan-Kettering Cancer Center)有 646 名年龄≥60 岁(654 例)的女性因 DCIS 接受手术治疗(8 例为双侧),包括广泛局部切除术(WLE;37%)、WLE 加放疗(WLE+RT;41%)或乳房切除术(22%)。分别有 45%、38%和 16%的 60-69 岁、70-79 岁和≥80 岁患者接受了 WLE+RT(P<0.001),分别有 25%、20%和 13%的患者接受了乳房切除术(P<0.001)。年龄(P<0.001)、分级(P<0.001)和坏死(P<0.01)与治疗高度相关。4 年局部复发率为 3.6%。总体局部复发与治疗相关(乳房切除术,0%;WLE,5%;WLE+RT,4%;P<0.00001),但与年龄无关。对于仅接受 WLE 治疗后复发风险可接受较低的老年 DCIS 患者,有可能确定。单独的 WLE 可能是老年 DCIS 患者的一种可行治疗选择。

相似文献

1
The effect of age in the outcome and treatment of older women with ductal carcinoma in situ.年龄对老年女性导管原位癌的结局和治疗的影响。
Breast. 2011 Feb;20(1):71-7. doi: 10.1016/j.breast.2010.07.005. Epub 2010 Aug 23.
2
Clinical outcome after selective treatment of patients diagnosed with ductal carcinoma in situ of the breast.对诊断为乳腺导管原位癌的患者进行选择性治疗后的临床结果。
Ann Surg Oncol. 2008 Jan;15(1):235-43. doi: 10.1245/s10434-007-9659-2. Epub 2007 Nov 7.
3
Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Group and EORTC Radiotherapy Group.导管原位癌保乳治疗加或不加放疗:欧洲癌症研究与治疗组织III期随机试验10853的十年结果——欧洲癌症研究与治疗组织乳腺癌协作组和欧洲癌症研究与治疗组织放疗组的一项研究
J Clin Oncol. 2006 Jul 20;24(21):3381-7. doi: 10.1200/JCO.2006.06.1366. Epub 2006 Jun 26.
4
Factors associated with local recurrence and cause-specific survival in patients with ductal carcinoma in situ of the breast treated with breast-conserving therapy or mastectomy.接受保乳治疗或乳房切除术的乳腺导管原位癌患者局部复发及特定病因生存率的相关因素。
Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1514-21. doi: 10.1016/j.ijrobp.2005.04.045. Epub 2005 Jul 11.
5
259 Patients with DCIS of the breast applying USC/Van Nuys prognostic index: a retrospective review with long term follow up.应用USC/范纽斯预后指数的259例乳腺导管原位癌患者:长期随访的回顾性研究
Breast Cancer Res Treat. 2008 Jun;109(3):405-16. doi: 10.1007/s10549-007-9668-7. Epub 2007 Aug 9.
6
Outcomes of screening-detected ductal carcinoma in situ treated with wide excision alone.单纯广泛切除治疗筛查检出的导管原位癌的结局。
Ann Surg Oncol. 2011 Dec;18(13):3778-84. doi: 10.1245/s10434-011-1748-6. Epub 2011 Jun 1.
7
Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.保乳手术后切缘接近或局灶受累的乳腺导管原位癌:再次切除或增加剂量放疗的治疗方法
Int J Radiat Oncol Biol Phys. 2009 Nov 15;75(4):1021-8. doi: 10.1016/j.ijrobp.2008.12.014. Epub 2009 Apr 20.
8
Effectiveness of radiation therapy in older women with ductal carcinoma in situ.放射治疗对老年导管原位癌女性患者的疗效
J Natl Cancer Inst. 2006 Sep 20;98(18):1302-10. doi: 10.1093/jnci/djj359.
9
Local recurrence after conservative surgery and radiation therapy for ductal carcinoma in situ: Possible importance of family history.导管原位癌保守手术及放疗后的局部复发:家族史的潜在重要性
Cancer J Sci Am. 1995 May-Jun;1(1):55-61.
10
Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast.乳腺导管原位癌患者同侧局部复发与治疗及形态学特征的关系
Eur J Surg Oncol. 2000 Aug;26(5):444-51. doi: 10.1053/ejso.1999.0919.

引用本文的文献

1
Associations of clinicopathological factors with local treatment and survival outcome in elderly patients with ductal carcinoma .老年导管癌患者临床病理因素与局部治疗及生存结果的相关性
Front Surg. 2023 May 5;10:1074980. doi: 10.3389/fsurg.2023.1074980. eCollection 2023.
2
Delay in radiotherapy is associated with an increased risk of disease recurrence in women with ductal carcinoma in situ.对于导管原位癌女性患者,放疗延迟与疾病复发风险增加相关。
Cancer. 2018 Jan 1;124(1):46-54. doi: 10.1002/cncr.30972. Epub 2017 Sep 28.
3
Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
1657例乳腺单纯导管原位癌患者的微钙化:与临床、组织病理学、生物学特征及局部复发的相关性
Ann Surg Oncol. 2016 Feb;23(2):482-9. doi: 10.1245/s10434-015-4876-6. Epub 2015 Sep 28.
4
DEGRO practical guidelines: radiotherapy of breast cancer II: radiotherapy of non-invasive neoplasia of the breast.DEGRO 实践指南:乳腺癌放疗 II:乳腺非浸润性肿瘤放疗。
Strahlenther Onkol. 2014 Jan;190(1):8-16. doi: 10.1007/s00066-013-0502-3.
5
Blurry boundaries: do epithelial borderline lesions of the breast and ductal carcinoma in situ have similar rates of subsequent invasive cancer?界限模糊:乳腺上皮边界病变和导管原位癌的后续浸润性癌发生率是否相似?
Ann Surg Oncol. 2013 Apr;20(4):1302-10. doi: 10.1245/s10434-012-2719-2. Epub 2012 Nov 19.
6
Memorial sloan-kettering cancer center: two decades of experience with ductal carcinoma in situ of the breast.纪念斯隆凯特琳癌症中心:二十年乳腺导管原位癌治疗经验
Int J Surg Oncol. 2012;2012:723916. doi: 10.1155/2012/723916. Epub 2012 May 23.
7
Biology, treatment, and outcome in very young and older women with DCIS.非常年轻和老年女性 DCIS 的生物学、治疗和结果。
Ann Surg Oncol. 2012 Nov;19(12):3777-84. doi: 10.1245/s10434-012-2413-4. Epub 2012 May 24.